INNATE IMMUNOTHERAPEUTICS LTD has a total of 18 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are IMMODULON THERAPEUTICS LTD, STEALTH PEPTIDES INTERNAT INC and PROLONG PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | India | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Webster Gillian Alison | 15 |
#2 | Gelder Frank B | 9 |
#3 | Gillian Alison Webster | 1 |
#4 | Frank B Gelder B | 1 |
#5 | Frank B Gelder | 1 |
#6 | Mayell Frederick Edward | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017059486A1 | Compositions and methods for the treatment of epilepsy | |
WO2017070731A1 | Compositions and methods for the treatment of alzheimer's disease | |
CA2926507A1 | Compositions and methods for protection and/or repair of the nervous system | |
AU2009232504A1 | Compositions and methods for treatment of neoplastic disease |